Tung-Liang Lin
Overview
Explore the profile of Tung-Liang Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
611
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang S, Chang K, Chen W, Chou P, Chiu C, Liu Y, et al.
Respirol Case Rep
. 2025 Mar;
13(3):e70120.
PMID: 40065796
Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for multiple myeloma; however, the development of chronic graft-versus-host disease remains a significant challenge. Bronchiolitis obliterans syndrome (BOS) is one...
2.
Kao H, Kuo M, Ou C, Huang T, Chang H, Lin T, et al.
J Pathol
. 2025 Feb;
265(4):437-447.
PMID: 39905935
This study investigated the clonal evolution of chronic myelomonocytic leukemia (CMML) progression to secondary acute myeloid leukemia (sAML) by next-generation sequencing and pyrosequencing for variant allele frequency (VAF) of gene...
3.
Chuang C, Kuo M, Wu J, Lin T, Wang P, Chang Y, et al.
Arch Med Res
. 2024 Oct;
56(2):103109.
PMID: 39461040
Background And Aim: JAK2 exon 12 mutation status and the clinical characteristics of patients with polycythemia vera (PV) in Asia remain to be defined. Method: We analyzed the clinical, molecular,...
4.
Tseng C, Lin T, Tsai S, Lin W, Hsu F, Wang W, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200825
: Hematopoietic stem cell transplantation (HSCT) is one of the mainstream treatments for patients with hematologic malignancies. The matching status of human leukocyte antigen (HLA) between the donor and recipient...
5.
Huang Y, Chen S, Liu H, Jaing T, Yeh T, Kuo M, et al.
Pathology
. 2024 May;
56(5):681-687.
PMID: 38719770
The use of next-generation sequencing (NGS) for monitoring measurable residual disease (MRD) in acute lymphoblastic leukaemia (ALL) has been gaining traction. This study aimed to investigate the utility of NGS...
6.
Huang Y, Hsiao F, Guan S, Yao M, Liu C, Chen T, et al.
J Microbiol Immunol Infect
. 2024 Mar;
57(3):365-374.
PMID: 38503632
Background: Cytomegalovirus (CMV) can cause infection and critical diseases in hematopoietic stem cell transplantation (HSCT) recipients. This study aimed to explore the cumulative incidence and risk factors for CMV infection...
7.
Chan C, Ou C, Chang H, Kuo M, Lin T, Hung Y, et al.
J Formos Med Assoc
. 2024 Jan;
123(10):1078-1086.
PMID: 38296697
Background: Primary breast diffuse large B-cell lymphoma (PB-DLBCL) is rare, with a high incidence of central nervous system (CNS) relapse. This study aims to investigate clinical characteristics, prognostic factors, and...
8.
Shih H, Kuo M, Lin T, Kao H, Wu J, Hung Y, et al.
Oncol Lett
. 2024 Jan;
27(2):57.
PMID: 38192663
The effective prognostic factors for primary mediastinal large B-cell lymphoma (PMLBCL) vary among published studies. The aim of the present study was to explore the factors influencing the overall survival...
9.
Li H, Huang C, Lui K, Chao Y, Yeh C, Lee L, et al.
Transl Oncol
. 2023 Sep;
38:101785.
PMID: 37713975
Background: Nasopharyngeal carcinoma (NPC) is associated with Epstein-Barr virus (EBV) infection. To test preclinical NPC drugs, we established two patient-derived xenograft (PDX) mouse models, EBV-positive PDX-B13 and EBV-negative PDX-Li41, for...
10.
Chuang C, Kuo M, Chang H, Wu J, Hung Y, Ou C, et al.
Clin Exp Med
. 2023 Sep;
23(8):5327-5336.
PMID: 37679606
To explore prognostic factors and outcomes of primary central nervous system lymphoma (PCNSL) of diffuse large B-cell lymphoma (DLBCL) in Taiwan, 124 PCNSL-DLBCL patients (from 1995 to 2021) were retrospectively...